Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Multiple Year (2006 ~ 2010) Child Asthma Call-back Survey Prevalence Tables

TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among children1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2006-2010
State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Arizona 125 25.9 6.0 (14.1 – 37.7) 149 23.4 5.3 (13.0 – 33.8)
California 170 28.0 4.4 (19.4 – 36.6) 206 23.9 3.6 (16.8 – 31.0)
Connecticut 347 26.8 3.0 (20.9 – 32.7) 413 23.2 2.6 (18.1 – 28.3)
District of Columbia 114 25.5 4.5 (16.7 – 34.3) 140 23.3 3.9 (15.7 – 30.9)
Georgia 341 24.6 3.2 (18.3 – 30.9) 399 22.0 2.8 (16.5 – 27.5)
Hawaii 417 20.0 2.6 (14.9 – 25.1) 444 19.8 2.4 (15.1 – 24.5)
Illinois 168 25.8 4.4 (17.2 – 34.4) 196 22.8 3.9 (15.2 – 30.4)
Indiana 348 30.2 3.2 (23.9 – 36.5) 391 25.8 2.9 (20.1 – 31.5)
Iowa 249 20.0 2.9 (14.3 – 25.7) 274 17.8 2.6 (12.7 – 22.9)
Kansas 588 32.1 2.3 (27.6 – 36.6) 657 29.3 2.1 (25.2 – 33.4)
Louisiana 107 19.0 4.1 (11.0 – 27.0) 122 17.1 3.7 (9.8 – 24.4)
Maine 284 34.8 3.3 (28.3 – 41.3) 332 30.1 3.0 (24.2 – 36.0)
Maryland 385 21.7 2.5 (16.8 – 26.6) 467 17.8 2.1 (13.7 – 21.9)
Massachusetts 269 31.7 4.1 (23.7 – 39.7) 315 27.6 3.7 (20.3 – 34.9)
Michigan 480 30.5 2.8 (25.0 – 36.0) 533 28.7 2.6 (23.6 – 33.8)
Mississippi 80 21.4 6.2 (9.2 – 33.6) 94 18.3 5.4 (7.7 – 28.9)
Missouri 230 31.6 4.4 (23.0 – 40.2) 255 28.3 4.2 (20.1 – 36.5)
Montana 210 28.4 3.9 (20.8 – 36.0) 253 26.0 3.5 (19.1 – 32.9)
Nebraska 467 30.2 3.7 (22.9 – 37.5) 528 27.8 3.4 (21.1 – 34.5)
New Hampshire 150 26.3 4.1 (18.3 – 34.3) 173 23.6 3.7 (16.3 – 30.9)
New Jersey 296 21.7 3.2 (15.4 – 28.0) 337 19.5 3.0 (13.6 – 25.4)
New Mexico 234 21.5 3.8 (14.1 – 28.9) 262 19.5 3.4 (12.8 – 26.2)
New York 276 23.3 3.3 (16.8 – 29.8) 336 19.2 2.7 (13.9 – 24.5)
North Dakota 98 25.4 5.4 (14.8 – 36.0) 120 19.6 4.6 (10.6 – 28.6)
Ohio 222 25.3 4.4 (16.7 – 33.9) 258 21.1 3.8 (13.7 – 28.5)
Oklahoma 250 32.1 3.5 (25.2 – 39.0) 256 31.7 3.5 (24.8 – 38.6)
Oregon 193 19.6 2.9 (13.9 – 25.3) 224 18.5 2.7 (13.2 – 23.8)
Pennsylvania 134 28.2 4.7 (19.0 – 37.4) 156 23.9 4.0 (16.1 – 31.7)
Rhode Island 153 32.6 4.2 (24.4 – 40.8) 180 30.2 3.8 (22.8 – 37.6)
Texas 479 27.6 3.3 (21.1 – 34.1) 558 23.2 2.9 (17.5 – 28.9)
Utah 368 30.6 3.8 (23.2 – 38.0) 414 28.9 3.5 (22.0 – 35.8)
Vermont 389 36.0 2.8 (30.5 – 41.5) 443 33.1 2.7 (27.8 – 38.4)
Virginia 88 35.7 8.7 (18.6 – 52.8) 100 33.7 8.1 (17.8 – 49.6)
Washington 341 23.7 2.9 (18.0 – 29.4) 389 22.8 2.9 (17.1 – 28.5)
West Virginia 193 22.2 3.4 (15.5 – 28.9) 213 20.1 3.1 (14.0 – 26.2)
Wisconsin 147 28.6 4.8 (19.2 – 38.0) 206 22.2 3.7 (14.9 – 29.5)
36 state total 9,390 26.8 1.0 (24.8 – 28.8) 10,793 23.4 0.9 (21.6 – 25.2)
Median 26.6 23.3
Range 19.0-36.0 17.1-33.7

1 Aged < 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Sample size is for multiple years of participation. Responses of “Don’t Know” and “Refused” are excluded.

§ Standard error

Confidence interval

TOP